Malcolm Kendrick

730 total citations
12 papers, 395 citations indexed

About

Malcolm Kendrick is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Malcolm Kendrick has authored 12 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Economics and Econometrics. Recurrent topics in Malcolm Kendrick's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Malcolm Kendrick is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Malcolm Kendrick collaborates with scholars based in United Kingdom, United States and France. Malcolm Kendrick's co-authors include Uffe Ravnskov, David M. Diamond, Sherif Sultan, Tomohito Hamazaki, Harumi Okuyama, Peter H. Langsjoen, Björn Hammarskjöld, Ralf Sundberg, Kevin K. McCully and Luca Mascitelli and has published in prestigious journals such as International Journal of Molecular Sciences, BMJ Open and PharmacoEconomics.

In The Last Decade

Malcolm Kendrick

12 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm Kendrick United Kingdom 8 192 151 75 70 69 12 395
Ángel Díaz Rodríguez Spain 11 165 0.9× 145 1.0× 47 0.6× 77 1.1× 43 0.6× 56 343
Jane K. Stock France 9 263 1.4× 90 0.6× 31 0.4× 92 1.3× 95 1.4× 40 436
Gerald Klose Germany 13 222 1.2× 218 1.4× 65 0.9× 130 1.9× 37 0.5× 43 547
Evertine J. Abbink Netherlands 14 374 1.9× 328 2.2× 49 0.7× 123 1.8× 99 1.4× 34 728
Cecilie Wium Norway 11 152 0.8× 99 0.7× 89 1.2× 57 0.8× 22 0.3× 21 516
Vasilisa Sazonov United States 13 315 1.6× 191 1.3× 53 0.7× 128 1.8× 143 2.1× 23 526
Euridiki Drogari Greece 12 373 1.9× 182 1.2× 33 0.4× 83 1.2× 60 0.9× 19 544
Junghyun Noh South Korea 3 141 0.7× 122 0.8× 42 0.6× 72 1.0× 29 0.4× 3 370
Mats Martinell Sweden 19 218 1.1× 460 3.0× 93 1.2× 149 2.1× 28 0.4× 39 815
Enas A Enas United States 7 145 0.8× 213 1.4× 53 0.7× 112 1.6× 32 0.5× 8 421

Countries citing papers authored by Malcolm Kendrick

Since Specialization
Citations

This map shows the geographic impact of Malcolm Kendrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Kendrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Kendrick more than expected).

Fields of papers citing papers by Malcolm Kendrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Kendrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Kendrick. The network helps show where Malcolm Kendrick may publish in the future.

Co-authorship network of co-authors of Malcolm Kendrick

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Kendrick. A scholar is included among the top collaborators of Malcolm Kendrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Kendrick. Malcolm Kendrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kendrick, Malcolm. (2022). Assessing cardiovascular disease: looking beyond cholesterol. Current Opinion in Endocrinology Diabetes and Obesity. 29(5). 427–433. 3 indexed citations
2.
Ravnskov, Uffe, Michel de Lorgeril, Malcolm Kendrick, & David M. Diamond. (2022). Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia. International Journal of Molecular Sciences. 23(16). 9146–9146. 10 indexed citations
3.
Ravnskov, Uffe, Abdullah Alabdulgader, Michel de Lorgeril, et al.. (2020). The new European guidelines for prevention of cardiovascular disease are misleading. Expert Review of Clinical Pharmacology. 13(12). 1289–1294. 9 indexed citations
4.
Ravnskov, Uffe, Michel de Lorgeril, Malcolm Kendrick, & David M. Diamond. (2018). Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia. Medical Hypotheses. 121. 60–63. 12 indexed citations
5.
Ravnskov, Uffe, Michel de Lorgeril, David M. Diamond, et al.. (2018). LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature. Expert Review of Clinical Pharmacology. 11(10). 959–970. 93 indexed citations
6.
Ravnskov, Uffe, David M. Diamond, Tomohito Hamazaki, et al.. (2016). Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 6(6). e010401–e010401. 207 indexed citations
7.
Ravnskov, Uffe, Tomohito Hamazaki, Björn Hammarskjöld, et al.. (2016). Lack of an association or an inverse association between low-density lipoprotein cholesterol and mortality in the elderly: a systematic review. 4(4). 45–45. 7 indexed citations
8.
Kendrick, Malcolm. (2007). Are statins overused?. 2(5). 481–483. 2 indexed citations
9.
Kendrick, Malcolm. (2002). Does insulin resistance cause atherosclerosis in the post-prandial period?. Medical Hypotheses. 60(1). 6–11. 3 indexed citations
10.
Kendrick, Malcolm, et al.. (2000). Long Term Treatment of Multiple Sclerosis with Interferon-?? May Be Cost Effective. PharmacoEconomics. 18(1). 45–53. 34 indexed citations
11.
Kendrick, Malcolm, et al.. (2000). Long Term Treatment of Multiple Sclerosis with Interferon-β May Be Cost Effective. 6 indexed citations
12.
Everson, Gregory T., et al.. (1993). Ineffectiveness of a mass mailing campaign to improve poison center awareness in a rural population.. PubMed. 35(2). 165–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ángel Díaz Rodríguez Breakdown of academic impact, for papers by Jane K. Stock Breakdown of academic impact, for papers by Gerald Klose Breakdown of academic impact, for papers by Evertine J. Abbink Breakdown of academic impact, for papers by Cecilie Wium Breakdown of academic impact, for papers by Vasilisa Sazonov Breakdown of academic impact, for papers by Euridiki Drogari Breakdown of academic impact, for papers by Junghyun Noh Breakdown of academic impact, for papers by Mats Martinell Breakdown of academic impact, for papers by Enas A Enas
Rankless by CCL
2026